Patents by Inventor Roland Callens

Roland Callens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100280221
    Abstract: Processes for the synthesis and purification of a Gly-Gly-Val-Leu-Val-Gln-Pro-Gly octapeptide (SEQ ID NO 1).
    Type: Application
    Filed: November 21, 2008
    Publication date: November 4, 2010
    Applicant: SOLVAY (SOCIETE ANONYME)
    Inventors: Roland Callens, Georges Blondeel, Thierry Delplanche
  • Patent number: 7767073
    Abstract: Use of an organic compound salt of general formula A-XY??(I) wherein A means an organic residue, X means a charged group and Y means a counter-ion, as a reagent in an electrochemical reaction and organic compound salt corresponding to the formula R1R2ZC-T-Q-XY wherein X is a charged group, Y is a counter-ion, Z is a group capable of being substituted, R1 and R2 mean organic residues, T means a group containing a hetero atom selected among N-R4, O and S, and Q means a connecting group linking the hetero atom and the charged group.
    Type: Grant
    Filed: September 10, 2003
    Date of Patent: August 3, 2010
    Assignee: Solvay S.A.
    Inventors: Roland Callens, Frank Becu, Frans Borremans, Franky Fant
  • Publication number: 20090326195
    Abstract: A process for manufacturing a cyclic peptide which comprises providing a cyclic peptide bonded to a Merrifield-type resin and cleaving the cyclic peptide from the Merrifield type resin by transesterification.
    Type: Application
    Filed: July 17, 2007
    Publication date: December 31, 2009
    Applicant: SOLVAY (Societe Anonyme)
    Inventors: Satish Joshi, Shima Joshi, Bernhard Freimann, Manuel Ramos, Roland Callens
  • Patent number: 7592476
    Abstract: Process for producing enantiopure ?-amino acid derivatives corresponding to general formula (I) R1-NZ-CHR2-CH2—COOR3 (I) in which R1 and R2 independently denote organic residues optionally forming a cyclic substituent, R3 denotes H or an organic residue, and Z represents H or an amino function-protecting group, comprising a step in which a mixture of enantiomers of a compound corresponding to general formula (II) R1-NZ-CHR2—CH2—COOR4 (II) in which R1, R2 and Z are as defined for formula (I), and R4 is an organic residue, is subjected to hydrolysis in the presence of a lipase.
    Type: Grant
    Filed: April 2, 2004
    Date of Patent: September 22, 2009
    Assignee: Solvay S.A.
    Inventors: Roland Callens, Marc Larcheveque, Cyrille Pousset
  • Patent number: 7538245
    Abstract: Process for the manufacture of an enantiopure compound comprising at least one functional group capable of reacting with an activated carboxyl group, starting from a mixture of enantiomers of the said compound, in which process: (a) a reaction medium comprising the mixture of enantiomers and a reagent based on an enantiopure amino acid, in which reagent at least one amino group of the amino acid is protected by a protective group and in which reagent at least one carboxyl group of the amino acid is activated, is subjected to conditions appropriate for bringing about the reaction of the functional group capable of reacting with the activated carboxyl group with the activated carboxyl group, so as to form a carbonyl bond; (b) the mixture of diastereomers obtained is subjected to a separation operation, so as to obtain at least one fraction composed essentially of a diastereomer, (c) at least a portion of the said fraction is subjected to a stage of cleavage of the carbonyl bond under conditions under which the
    Type: Grant
    Filed: September 8, 2004
    Date of Patent: May 26, 2009
    Assignee: Solvay S.A.
    Inventors: Roland Callens, Georges Blondeel, Cyrille Pousset, Ronan Gire
  • Patent number: 7528228
    Abstract: Method for preparing a peptide or a peptide derivative comprising at least 2 enantiopure amino acids and at least one glycine molecule, comprising the reaction of a compound of general formula XCH2—C(?O)—HN-A-COOY (II) with a compound of general formula HNR1R2 (III).
    Type: Grant
    Filed: October 2, 2003
    Date of Patent: May 5, 2009
    Assignee: Solvay S.A.
    Inventors: Roland Callens, Frank Becu, Frans Borremans
  • Publication number: 20080027211
    Abstract: Enantiopure heterocyclic compound Enantiopure heterocyclic compound of formula (I) in which J is chosen from C, N, O and S; Z is H or a group for protecting the amino functional group, R3 denotes H or an organic residue, m is 0, 1 or 2 and n is 0, 1 or 2, and in which the heterocycle is preferably substituted with at least one substituent other than CH2—COOR3.
    Type: Application
    Filed: October 4, 2005
    Publication date: January 31, 2008
    Applicant: SOLVAY S.A.
    Inventors: Roland Callens, Cyrille Pousset
  • Patent number: 7176223
    Abstract: Process for the synthesis of 5-(3-pyridylmethyl)imidazolidine-2,4-dione, according to which 5-(3-pyridylmethylene)imidazolidine-2,4-dione is subjected to a hydrogenation reaction.
    Type: Grant
    Filed: October 24, 2005
    Date of Patent: February 13, 2007
    Assignee: Solvay S.A.
    Inventor: Roland Callens
  • Publication number: 20070027326
    Abstract: Process for the manufacture of an enantiopure compound comprising at least one functional group capable of reacting with an activated carboxyl group, starting from a mixture of enantiomers of the said compound, in which process: (a) a reaction medium comprising the mixture of enantiomers and a reagent based on an enantiopure amino acid, in which reagent at least one amino group of the amino acid is protected by a protective group and in which reagent at least one carboxyl group of the amino acid is activated, is subjected to conditions appropriate for bringing about the reaction of the functional group capable of reacting with the activated carboxyl group with the activated carboxyl group, so as to form a carbonyl bond; (b) the mixture of diastereomers obtained is subjected to a separation operation, so as to obtain at least one fraction composed essentially of a diastereomer, (c) at least a portion of the said fraction is subjected to a stage of cleavage of the carbonyl bond under conditions under which the
    Type: Application
    Filed: September 8, 2004
    Publication date: February 1, 2007
    Inventors: Roland Callens, Georges Blondeel, Cyrille Pousset, Ronan Gire
  • Publication number: 20060276673
    Abstract: Process for producing amino acid derivatives, in which (a) an organic amine, the amino functionality of which is protected, or an ?-amino acid, the amino functionality of which is protected, is subjected to an electrochemical reaction so as to form an amine which is activated in the ?-position; (b) the activated amine is subjected to a reaction with a carbanionic reagent containing at least 3 carbon atoms and comprising an unsaturated group so as to form an unsaturated amine comprising an unsaturated group, the atom of the unsaturated group closest to the nitrogen being separated from the nitrogen by at least 2 carbon atoms; (c) the unsaturated amine is subjected to oxidation of the unsaturated group so as to form an amino acid derivative.
    Type: Application
    Filed: April 2, 2004
    Publication date: December 7, 2006
    Applicant: Solvay S.A.
    Inventors: Roland Callens, Marc Laroheveque, Cyrille Pousset
  • Patent number: 7138538
    Abstract: Process for the separation of enantiomers comprising at least one free functional group, in which process a reagent based on an enantiopure amino acid is reacted in basic medium with a mixture comprising enantiomers.
    Type: Grant
    Filed: May 7, 2004
    Date of Patent: November 21, 2006
    Assignee: Solvay (Societe Anonyme)
    Inventors: Thierry Delplanche, Roland Callens
  • Publication number: 20060211097
    Abstract: Process for producing enantiopure ?-amino acid derivatives corresponding to general formula (I) R1-NZ-CHR2—CH2—COOR3 (I) in which R1 and R2 independently denote organic residues optionally forming a cyclic substituent, R3 denotes H or an organic residue, and Z represents H or an amino function-protecting group, comprising a step in which a mixture of enantiomers of a compound corresponding to general formula (II) R1-NZ-CHR2—CH2—COOR4 (II) in which R1, R2 and Z are as defined for formula (I), and R4 is an organic residue, is subjected to hydrolysis in the presence of a lipase.
    Type: Application
    Filed: April 2, 2004
    Publication date: September 21, 2006
    Applicant: Solvay S.A.
    Inventors: Roland Callens, Marc Larcheveque, Cyrille Pousset
  • Patent number: 7030214
    Abstract: Ureins are obtained by reaction, in basic medium, between an N?-(aryloxycarbonyl)diamino acid and a compound containing a free amino group. The chirality of the compounds is outstandingly well preserved.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: April 18, 2006
    Assignee: Solvay (Societe Anonyme)
    Inventors: Roland Callens, Georges Blondeel, Marc Anteunis, Frank Becu
  • Publication number: 20060049061
    Abstract: Use of an organic compound salt of general formula A-XY ??(I) wherein A means an organic residue, X means a charged group and Y means a counter-ion, as a reagent in an electrochemical reaction and organic compound salt corresponding to the formula R1R2ZC-T-Q-XY wherein X is a charged group, Y is a counter-ion, Z is a group capable of being substituted, R1 and R2 mean organic residues, T means a group containing a hetero atom selected among N-R4, O and S, and Q means a connecting group linking the hetero atom and the charged group.
    Type: Application
    Filed: September 10, 2003
    Publication date: March 9, 2006
    Inventors: Roland Callens, Frank Becu, Frans Borremans, Franky Fant
  • Publication number: 20060041143
    Abstract: Process for the synthesis of 5-(3-pyridylmethyl)imidazolidine-2,4-dione, according to which 5-(3-pyridylmethylene)imidazolidine-2,4-dione is subjected to a hydrogenation reaction.
    Type: Application
    Filed: October 24, 2005
    Publication date: February 23, 2006
    Applicant: SOLVAY S.A.
    Inventor: Roland Callens
  • Patent number: 6967253
    Abstract: Process for the synthesis of 5-(3-pyridylmethyl)imidazolidine-2,4-dione, according to which 5-(3-pyridylmethylene)imidazolidine-2,4-dione is subjected to a hydrogenation reaction.
    Type: Grant
    Filed: September 2, 2002
    Date of Patent: November 22, 2005
    Assignee: Solvay (Societe Anonyme)
    Inventor: Roland Callens
  • Publication number: 20040242892
    Abstract: Process for the synthesis of 5-(3-pyridylmethyl)imidazolidine-2,4-dione, according to which 5-(3-pyridylmethylene)imidazolidine-2,4-dione is subjected to a hydrogenation reaction.
    Type: Application
    Filed: March 5, 2004
    Publication date: December 2, 2004
    Inventor: Roland Callens
  • Publication number: 20040210060
    Abstract: Process for the separation of enantiomers comprising at least one free functional group, in which process a reagent based on an enantiopure amino acid is reacted in basic medium with a mixture comprising enantiomers.
    Type: Application
    Filed: May 7, 2004
    Publication date: October 21, 2004
    Applicant: SOLVAY S.A.
    Inventors: Thierry Delplanche, Roland Callens
  • Patent number: 6743373
    Abstract: Process for the separation of enantiomers comprising at least one free functional group, in which process a reagent based on an enantiopure amino acid is reacted in basic medium with a mixture comprising enantiometers.
    Type: Grant
    Filed: April 14, 2000
    Date of Patent: June 1, 2004
    Assignee: Solvay (Societe Anonyme)
    Inventors: Thierry Delplanche, Roland Callens
  • Publication number: 20040077830
    Abstract: Method for preparing a peptide or a peptide derivative comprising at least 2 enantiopure amino acids and at least one glycine molecule, comprising the reaction of a compound of general formula XCH2—C(═O)—HN—A—COOY (II) with a compound of general formula HNR1R2 (III).
    Type: Application
    Filed: October 2, 2003
    Publication date: April 22, 2004
    Inventors: Roland Callens, Frank Becu, Frans Borremans